tiprankstipranks
Cordlife Group (SG:P8A)
:P8A
Singapore Market
Holding SG:P8A?
Track your performance easily

Cordlife Group (P8A) Share Price & Analysis

1 Followers

P8A Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.12%99.88%
Insiders
0.12% Other Institutional Investors
99.88% Public Companies and
Individual Investors

P8A FAQ

What was Cordlife Group ’s price range in the past 12 months?
Cordlife Group lowest share price was S$0.12 and its highest was S$0.32 in the past 12 months.
    What is Cordlife Group ’s market cap?
    Cordlife Group ’s market cap is S$38.30M.
      When is Cordlife Group ’s upcoming earnings report date?
      Cordlife Group ’s upcoming earnings report date is Feb 27, 2025 which is in 44 days.
        How were Cordlife Group ’s earnings last quarter?
        Currently, no data Available
        Is Cordlife Group overvalued?
        According to Wall Street analysts Cordlife Group ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Cordlife Group pay dividends?
          Cordlife Group does not currently pay dividends.
          What is Cordlife Group ’s EPS estimate?
          Cordlife Group ’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Cordlife Group have?
          Cordlife Group has 267,525,360 shares outstanding.
            What happened to Cordlife Group ’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Cordlife Group ?
            Currently, no hedge funds are holding shares in SG:P8A
            ---

            Company Description

            Cordlife Group

            Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood banking services. It operates through the Banking and Diagnostics segments. The Banking segment comprises of cord blood, and cord lining and tissue services, which collects, processes and stores in laboratories. The Diagnostics segment consists of Metascreen, which is anon-invasive metabolic screening test designed for newborn babies, non-invasive prenatal testing and eyescreen, and a paediatric vision-screening services. The company was founded on May 2, 2001 and is headquartered in Singapore.
            ---
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis